# BRK.B – Investment Thesis (Fermat–Pascal + Kelly System)

## 0. Meta

- **Ticker / Name**: BRK.B – Berkshire Hathaway Inc. Class B
- **As of**: 2025-11-15
- **Time Horizon**: 10+ years
- **Benchmark**: S&P 500 (long-term nominal ~7%/year)
- **Target CAGR (Hurdle)**: 10%+
- **Engine / Model**:
    - Engine: `fermat-pascal-kelly`
    - Use Monte Carlo: `false`
    - Kelly scale: `0.5`
- **Position (to fill in personally)**:
    - Current shares: {{BRK.B_shares}}
    - Current weight: {{BRK.B_weight_pct}}%
    - Max allowed position: 25%

---

## 1. Business Snapshot

### 1.1 What the company does

- **Segments**
    - **Insurance & Reinsurance**: GEICO, Berkshire Hathaway Reinsurance Group, General Re, specialty P&C. Generates underwriting profit and float.
    - **Railroad**: BNSF Railway – one of the two major U.S. Class I freight rails.
    - **Utilities & Energy**: Berkshire Hathaway Energy – regulated electric/gas utilities, pipelines, renewables, transmission.
    - **Manufacturing, Services, Retail**: Wide collection of industrial, building products, aerospace, consumer, and retail businesses.
    - **Investment Portfolio**: Large, concentrated equity portfolio (Apple, Bank of America, American Express, Coca-Cola, etc.) plus fixed income and cash.

- **Business model in one sentence**
  Use **insurance float + retained earnings** from a diversified set of high-quality operating businesses to compound capital over decades via disciplined investing, opportunistic acquisitions, and selective buybacks.

### 1.2 Why it’s in my universe

- **Role in portfolio**
    - Core long-term compounder / “internal hedge fund + conglomerate”.
    - Low probability of permanent capital loss; historically smaller drawdowns than the index.

- **My variant perception / edge**
    - Market **over-weights “life after Buffett” fear** and under-weights:
        - The depth of the **succession bench** (Greg Abel, Ajit Jain, Combs, Weschler).
        - The structural earnings power of a **huge, mostly cost-free float** in a higher-rate world.
        - The **optionality** of a ~$300B+ cash pile that can be deployed during crises.
    - I treat BRK as a quasi-index of quality businesses with an embedded “distressed-assets call option”.

---

## 2. Business Quality & Moat

### 2.1 Sources of moat

- **Insurance float**
    - Large, usually low- or no-cost float that can be invested for long periods.
    - Financial strength allows writing risks others can’t or won’t take.
- **Regulated / infrastructure assets**
    - BNSF and BHE have strong local monopoly or oligopoly positions, with high barriers to entry.
- **Scale and reputation**
    - Preferred buyer for private businesses.
    - Reputation for dealing fairly with counterparties and allowing autonomy to acquired firms.
- **Culture and decentralization**
    - Extreme decentralization with very lean HQ; talented managers run operating companies.
    - Long-term orientation and conservatism on leverage.

### 2.2 Unit economics & returns

- Insurance: target combined ratios ≲100 over the cycle; investment income on float is the main profit driver.
- Rail & utilities: capital-intensive, but steady mid-single to low-double digit ROEs on large equity bases.
- Manufacturing/services: mix of cyclical and steady businesses; aggregate returns roughly mid-teens on incremental invested capital over time.
- Overall: **moderated but still attractive ROE** given size; “better-than-average business, constrained by scale”.

### 2.3 Management & capital allocation

- **Management**
    - Historic: Buffett + Munger.
    - Future: Greg Abel (non-insurance ops), Ajit Jain (insurance), plus two investment managers.
- **Capital allocation**
    - History of value-accretive deals (BNSF, BHE, Alleghany, crisis-era preferreds).
    - Willing to sit on cash when opportunities are poor.
    - Opportunistic but disciplined buybacks when price < intrinsic value.
- **Alignment**
    - Senior leaders are large shareholders; culture emphasizes treating shareholders as partners.

---

## 3. Key Drivers & Risk Map

### 3.1 Long-term value drivers (10+ years)

- Growth in **operating earnings** across:
    - Insurance underwriting and float.
    - BNSF volumes and pricing.
    - BHE rate base and regulated returns.
    - Manufacturing/services growth and margin improvement.
- **Investment returns** on:
    - Equity portfolio (Apple + others).
    - T-bills and fixed income (higher yields than in ZIRP decade).
- **Capital deployment**:
    - Use of the cash pile for:
        - Major acquisition(s) at attractive valuations.
        - Opportunistic crisis investments (preferreds/structured deals).
        - Share repurchases when BRK trades at a discount to intrinsic value.

### 3.2 Main risks and “thesis killers”

- **Buffett succession / perception risk**
    - Market may permanently apply a lower multiple (“Buffett discount”) if Abel isn’t seen as a worthy successor.
- **Insurance risk / climate**
    - Higher frequency and severity of CAT events could structurally pressure combined ratios.
- **Capital allocation drift**
    - Excessive conservatism: cash piles up in T-bills, depressing returns.
    - Large, value-destructive acquisition.
- **Regulatory / political**
    - Adverse changes in utility regulation or rail pricing/competition.
    - Political backlash against large, successful conglomerates.

- **Thesis-kill triggers**
    - Multi-year pattern of clearly poor capital allocation decisions.
    - Persistent, structurally loss-making insurance operations (float becomes expensive).
    - Serious governance or accounting failure that undermines trust.

---

## 4. Current Valuation Snapshot

- **Price**: ≈ **$509** per B share.
- **Market cap**: ≈ **$1.1T**.
- **TTM EPS**: ≈ **$31** per B share.
- **TTM P/E**: ≈ **16×**.
- **Forward P/E**: ≈ low-20s on consensus EPS.
- **Price/Book**: ≈ **1.5×** (book value per B share ≈ mid-$300s).
- **EV / EBITDA**: ~low-teens.
- **5Y Beta**: ≈ **0.7** (lower volatility than the market).

**Takeaway**: Valuation is **roughly fair to slightly cheap** for a low-risk, diversified compounder with strong balance sheet and embedded optionality.

---

## 5. Scenario Framework (Fermat–Pascal)

We model three discrete 10-year scenarios: **Bull**, **Base**, **Bear**.
All returns are from today’s price over 10 years.

### 5.1 Shared modeling assumptions

- Start price: **$509**.
- Start EPS: **$31** (TTM, GAAP).
- Time horizon: **10 years**.
- No meaningful net leverage at holdco.
- Buybacks:
    - More material in Bull/Base when valuation is reasonable.
    - Minimal in Bear.

---

### 5.2 Bull Case – “Crisis Opportunist”

- **Probability**: 20%
- **EPS CAGR**: ~12%
- **Exit P/E**: 18×
- **Implied 10-yr price**: ≈ **$1,400+**
- **Implied 10-yr CAGR**: ≈ **11–13%**

#### Narrative – Bull Case

- Multiple market dislocations allow BRK to deploy a large portion of its cash at high IRRs (big deals, crisis preferreds).
- Insurance underwriting is strong; float grows and remains cost-free.
- BNSF and BHE compound earnings steadily; BHE benefits from large energy-transition capex.
- GEICO’s turnaround sticks; overall operating earnings grow double-digit.
- Abel proves his mettle, the “Buffett discount” fades, and the market rewards BRK with a small quality premium in the multiple.

---

### 5.3 Base Case – “Slow, Steady Compounding”

- **Probability**: 60%
- **EPS CAGR**: ~8–10% (midpoint 9%)
- **Exit P/E**: 15×
- **Implied 10-yr price**: ≈ **$900–1,000**
- **Implied 10-yr CAGR**: ≈ **7–10%**

#### Narrative – Base Case

- No heroics: U.S. economy muddles through; BRK’s operating businesses grow mid-single digits.
- Insurance underwriting roughly breakeven to modestly profitable over the cycle.
- BNSF/BHE grow with GDP and rate-base expansion; industrials are a mixed but net-positive bag.
- Cash is deployed conservatively into capex, small deals, and occasional buybacks.
- Market treats BRK as a “quality value conglomerate” at a mid-teens multiple.

---

### 5.4 Bear Case – “Buffett Discount & Drift”

- **Probability**: 20%
- **EPS CAGR**: ~2–3% (assume 2%)
- **Exit P/E**: 12×
- **Implied 10-yr price**: ≈ **$420–450**
- **Implied 10-yr CAGR**: ≈ **0% (flat in nominal terms)**

#### Narrative – Bear Case

- Market never fully trusts post-Buffett leadership; a persistent “Buffett/conglomerate discount” keeps the multiple low.
- Climate-driven CAT losses hurt insurance; pricing doesn’t fully compensate.
- Management is too cautious: huge cash balances are kept mostly in T-bills; few high-return deployments.
- Operating earnings grow slowly; book value grows but at a low rate; stock tread-water vs inflation.

---

### 5.5 Probabilistic summary

- **Scenario weights**
    - Bull: 20%
    - Base: 60%
    - Bear: 20%

- **Rough expected return**
    - Expected EPS CAGR ≈ **8–9%**.
    - Expected 10-yr price CAGR ≈ **~8.5%**.
    - This is **above** S&P 500 expectation (~7%) with **lower downside risk**.

---

## 6. Valuation Cross-Checks

### 6.1 Earnings & multiples view

- Base case EPS after 10 years:
    - Start EPS ≈ $31, grow at 9% → EPS ≈ $73.
    - At 15×, price ≈ $1,095 → ~8% CAGR (plus any small buyback boost).

### 6.2 Book value view

- Assume book value per B share grows ~7–8%/yr:
    - BVPS roughly doubles over 10–11 years.
    - If P/B stays ~1.5× → price doubles → ~7% CAGR.
    - If P/B inches up toward 1.7–1.8× on good execution, returns drift closer to 9–10% CAGR.

### 6.3 Sum-of-the-parts (conceptual)

- Insurance ops (incl. float economics).
- BNSF as standalone rail.
- BHE as standalone regulated utility/infrastructure.
- Manufacturing/services/retail as a basket.
- Equity portfolio + cash.
- SOTP generally suggests **intrinsic value modestly above current price**, especially if BHE/BNSF are valued at peer multiples.

---

## 7. Kelly Framework & Position Sizing

### 7.1 Edge vs benchmark

- Benchmark: S&P 500 @ ~7% expected nominal.
- BRK expected: ~8.5% with significantly lower tail risk / volatility.
- Edge is modest in magnitude but strong in **risk-adjusted** terms.

### 7.2 Kelly logic (high-level)

- Qualitative Kelly inputs:
    - Positive edge: expected alpha vs S&P ~1–2%/year.
    - Low probability of permanent impairment.
    - Volatility and drawdowns lower than the market.
- A strict Kelly model on a “low-loss, modest-edge” bet would suggest a very large weight.
- To avoid model error / over-concentration, I **cap at 0.5× Kelly**.

### 7.3 Practical portfolio rules

- **Target weight**: **10–20%** of equity portfolio.
- **Max policy weight**: 25%.
- **Interpretation**:
    - Treat BRK as a **core position** (top 1–2 holding).
    - It plays the role of:
        - U.S. quality equity core.
        - Internal “capital allocator / crisis investor”.
        - Partial substitute for some broad U.S. equity exposure.

---

## 8. Trading & Risk Management Plan

### 8.1 Add / buy rules

- Add more aggressively when:
    - P/B ≤ 1.4× and qualitative thesis intact.
    - Market or Berkshire-specific selloffs driven by sentiment (e.g., Buffett health/retirement headlines) without fundamental damage.
    - Model-implied 10-yr CAGR > 10–11%.

- Normal DCA / nibbling:
    - On moderate pullbacks vs recent highs.
    - When cash is available and portfolio is under target weight.

### 8.2 Trim / reduce rules

- Trim if:
    - P/B ≥ ~2.0× and expected 10-yr CAGR < 7%.
    - Position > 25% of portfolio after outperformance.
- Consider more material reduction if:
    - Evidence emerges of persistent capital allocation mistakes or structural impairment to insurance economics.

### 8.3 Thesis failure checklist

If **two or more** of the following hold for multiple years:

- Insurance combined ratios are structurally >100 with no convincing plan to fix.
- Cash stays bloated and is not deployed despite obvious opportunities.
- Large, clearly value-destructive deals are made.
- Leadership instability or governance issues appear.

→ Re-rate BRK from **core** to **neutral**, reduce to ≤5% weight or exit.

---

## 9. Monitoring & To-Do

### 9.1 Ongoing monitoring

- **Quantitative**
    - Operating EPS growth vs 8–10% target band.
    - Book value per share growth vs 7–8% target.
    - Size and composition of cash + float.
    - Buyback volume and average repurchase price.
    - Insurance combined ratios and premium growth.

- **Qualitative**
    - Execution and communication quality from Greg Abel.
    - Any major capital deployment (large M&A or crisis deals).
    - Regulatory developments in insurance, utilities, and rail.
    - Climate / CAT patterns and insurer pricing responses.

### 9.2 Open research items

- Build and maintain a simple SOTP model as a cross-check to the EPS/PE approach.
- Track peers and sector multiples (rails, utilities, P&C insurers) to see if BRK’s embedded assets deserve higher/lower marks.
- Re-read each new shareholder letter and major interview for updated clues on post-Buffett culture and capital allocation philosophy.

---

## 10. One-Line Thesis

> **BRK.B is a low-risk, diversified compounding machine that should modestly beat the S&P 500 over the next decade, with downside protected by fortress finances and upside driven by disciplined capital allocation and crisis-time opportunity, making it worthy of a 10–20% core portfolio allocation under a half-Kelly framework.**
